Silverfin false 31/03/2023 01/04/2022 31/03/2023 Dr Geer Hubregtse 02/11/2016 Dr Karen Luyt 02/11/2016 18 October 2023 The principal activity of the Company during the financial year was the provision of medical consultancy services. 10458771 2023-03-31 10458771 bus:Director1 2023-03-31 10458771 bus:Director2 2023-03-31 10458771 2022-03-31 10458771 core:CurrentFinancialInstruments 2023-03-31 10458771 core:CurrentFinancialInstruments 2022-03-31 10458771 core:ShareCapital 2023-03-31 10458771 core:ShareCapital 2022-03-31 10458771 core:RetainedEarningsAccumulatedLosses 2023-03-31 10458771 core:RetainedEarningsAccumulatedLosses 2022-03-31 10458771 core:OfficeEquipment 2022-03-31 10458771 core:OfficeEquipment 2023-03-31 10458771 bus:OrdinaryShareClass1 2023-03-31 10458771 bus:OrdinaryShareClass2 2023-03-31 10458771 2022-04-01 2023-03-31 10458771 bus:FullAccounts 2022-04-01 2023-03-31 10458771 bus:SmallEntities 2022-04-01 2023-03-31 10458771 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 10458771 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 10458771 bus:Director1 2022-04-01 2023-03-31 10458771 bus:Director2 2022-04-01 2023-03-31 10458771 core:OfficeEquipment 2022-04-01 2023-03-31 10458771 2021-04-01 2022-03-31 10458771 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 10458771 bus:OrdinaryShareClass1 2021-04-01 2022-03-31 10458771 bus:OrdinaryShareClass2 2022-04-01 2023-03-31 10458771 bus:OrdinaryShareClass2 2021-04-01 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 10458771 (England and Wales)

DR KAREN LUYT LTD

Unaudited Financial Statements
For the financial year ended 31 March 2023
Pages for filing with the registrar

DR KAREN LUYT LTD

Unaudited Financial Statements

For the financial year ended 31 March 2023

Contents

DR KAREN LUYT LTD

COMPANY INFORMATION

For the financial year ended 31 March 2023
DR KAREN LUYT LTD

COMPANY INFORMATION (continued)

For the financial year ended 31 March 2023
DIRECTORS Dr Geer Hubregtse
Dr Karen Luyt
REGISTERED OFFICE Greenway Barton
Rhode
Bridgwater
TA5 2AD
England
United Kingdom
COMPANY NUMBER 10458771 (England and Wales)
CHARTERED ACCOUNTANTS Francis Clark LLP
Blackbrook Gate 1
Blackbrook Business Park
Taunton
Somerset TA1 2PX
DR KAREN LUYT LTD

BALANCE SHEET

As at 31 March 2023
DR KAREN LUYT LTD

BALANCE SHEET (continued)

As at 31 March 2023
Note 2023 2022
£ £
Fixed assets
Tangible assets 3 4,956 2,240
4,956 2,240
Current assets
Debtors 4 3,059 603
Cash at bank and in hand 9,091 10,779
12,150 11,382
Creditors: amounts falling due within one year 5 ( 3,845) ( 4,075)
Net current assets 8,305 7,307
Total assets less current liabilities 13,261 9,547
Provision for liabilities ( 942) ( 426)
Net assets 12,319 9,121
Capital and reserves
Called-up share capital 6 100 100
Profit and loss account 12,219 9,021
Total shareholders' funds 12,319 9,121

For the financial year ending 31 March 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Dr Karen Luyt Ltd (registered number: 10458771) were approved and authorised for issue by the Board of Directors on 18 October 2023. They were signed on its behalf by:

Dr Geer Hubregtse
Director
DR KAREN LUYT LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2023
DR KAREN LUYT LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Dr Karen Luyt Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Greenway Barton, Rhode, Bridgwater, TA5 2AD, England, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of of approving these financial statements. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Therefore, the directors are satisfied that the going concern basis of preparation is correct.

Turnover

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the
ordinary course of the company's activities.

The company recognises revenue when services have been delivered.

Employee benefits

Defined contribution schemes
The company contributes to the directors' personal pension schemes. The assets of the schemes are held separately from those of the company. The contributions payable are charges to the profit and loss account.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a reducing balance basis over its expected useful life, as follows:

Office equipment 15 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the year, including directors 0 0

3. Tangible assets

Office equipment Total
£ £
Cost
At 01 April 2022 2,802 2,802
Additions 3,320 3,320
At 31 March 2023 6,122 6,122
Accumulated depreciation
At 01 April 2022 562 562
Charge for the financial year 604 604
At 31 March 2023 1,166 1,166
Net book value
At 31 March 2023 4,956 4,956
At 31 March 2022 2,240 2,240

4. Debtors

2023 2022
£ £
Trade debtors 2,420 0
Prepayments 639 603
3,059 603

5. Creditors: amounts falling due within one year

2023 2022
£ £
Amounts owed to directors 1,248 624
Accruals 1,189 1,080
Taxation and social security 1,408 2,371
3,845 4,075

6. Called-up share capital

2023 2022
£ £
Allotted, called-up and fully-paid
75 Ordinary A shares of £ 1.00 each 75 75
25 Ordinary B shares of £ 1.00 each 25 25
100 100